208 related articles for article (PubMed ID: 3767188)
21. The importance of phosphate in regulating plasma 1,25-(OH)2-vitamin D levels in humans: studies in healthy subjects in calcium-stone formers and in patients with primary hyperparathyroidism.
Gray RW; Wilz DR; Caldas AE; Lemann J
J Clin Endocrinol Metab; 1977 Aug; 45(2):299-306. PubMed ID: 885994
[TBL] [Abstract][Full Text] [Related]
22. Primary hyperparathyroidism.
Broadus AE
J Urol; 1989 Mar; 141(3 Pt 2):723-30. PubMed ID: 2918615
[TBL] [Abstract][Full Text] [Related]
23. [Predictive value of lithogenic risk in hypercalciuria: should 24-hour urine calcium be measured?].
Ulmann A
Nephrologie; 1984; 5(5):232-4. PubMed ID: 6531063
[TBL] [Abstract][Full Text] [Related]
24. [Calcium stones: are current metabolic studies warranted in everyday practice?].
Evrard P; Boccon-Gibod L
Ann Urol (Paris); 1985; 19(5):309-12. PubMed ID: 4083838
[TBL] [Abstract][Full Text] [Related]
25. Idiopathic hypercalciuria: a mixed bag of stones.
Sherwood LM
J Lab Clin Med; 1977 Dec; 90(6):951-4. PubMed ID: 925483
[No Abstract] [Full Text] [Related]
26. Incidence of normocalcemic hyperparathyroidism in idiopathic hypercalciuria: evaluation by dietary calcium deprivation test.
Mazzuoli GF; D'Erasmo E; Minisola S; Mancini D; Malaguti Aliberti L; Scarda A; Bracci U; Miano L
Eur Urol; 1981; 7(6):331-4. PubMed ID: 6269860
[TBL] [Abstract][Full Text] [Related]
27. The cause of maintained hypercalciuria after the surgical cure of primary hyperparathyroidism is a defect in renal calcium reabsorption.
Farias ML; Delgado AG; Rosenthal D; Vieira JG; Kasamatsu T; Lazarevitch MJ; Pereira MF; Lima MB
J Endocrinol Invest; 1996 Jan; 19(1):12-20. PubMed ID: 8851686
[TBL] [Abstract][Full Text] [Related]
28. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
29. [Evaluation of hyperparathyroidism and recurrent renal lithiasis].
Bernheim J; Pozet N; Zech P; Archimbaud JP; Dubernard JM; Traeger J; Perrin J
J Urol Nephrol (Paris); 1975; 81(10-11):824-30. PubMed ID: 1219134
[No Abstract] [Full Text] [Related]
30. Renal stone disease: Causes, evaluation and medical treatment.
Heilberg IP; Schor N
Arq Bras Endocrinol Metabol; 2006 Aug; 50(4):823-31. PubMed ID: 17117307
[TBL] [Abstract][Full Text] [Related]
31. [Hypercalciuric and hyperparathyroid renal lithiasis].
Rapado A; de la Calle H; Castrillo JM; Mancha A; Traba ML; Cifuentes Delatte L
Minerva Med; 1976 Nov; 67(55):3573-81. PubMed ID: 995303
[TBL] [Abstract][Full Text] [Related]
32. Oxalate metabolism in renal stone disease with special reference to calcium metabolism and intestinal absorption.
Lindsjö M
Scand J Urol Nephrol Suppl; 1989; 119():1-53. PubMed ID: 2669121
[TBL] [Abstract][Full Text] [Related]
33. [Clinical and laboratory parameters in patients with urolithiasis in the presence and absence of primary hyperparathyroidism].
Dzerganov NK; Egshatian LV; Mokrysheva NG; Peretokina EV
Urologiia; 2013; (6):14-8. PubMed ID: 24649757
[TBL] [Abstract][Full Text] [Related]
34. Evidence for secondary hyperparathyroidism in idiopathic hypercalciuria.
Coe FL; Canterbury JM; Firpo JJ; Reiss E
J Clin Invest; 1973 Jan; 52(1):134-42. PubMed ID: 4682379
[TBL] [Abstract][Full Text] [Related]
35. [Vertebral density of hypercalciuric lithiasis. Its relation to calcium-protein intake and vitamin D metabolism].
Lalau JD; Achard JM; Bataille P; Bergot C; Jans I; Boudailliez B; Petit J; Henon G; Westeel PF; el Esper N
Ann Med Interne (Paris); 1992; 143(5):293-8. PubMed ID: 1482031
[TBL] [Abstract][Full Text] [Related]
36. Risk factors associated to kidney stones in primary hyperparathyroidism.
Corbetta S; Baccarelli A; Aroldi A; Vicentini L; Fogazzi GB; Eller-Vainicher C; Ponticelli C; Beck-Peccoz P; Spada A
J Endocrinol Invest; 2005 Feb; 28(2):122-8. PubMed ID: 15887857
[TBL] [Abstract][Full Text] [Related]
37. Serum ionized calcium and parathyroid hormone in renal stone disease.
Muldowney FP; Freaney R; McMullin JP; Towers RP; Spillane A; O'Connor P; O'Donohoe P; Moloney M
Q J Med; 1976 Jan; 45(177):75-86. PubMed ID: 1257401
[TBL] [Abstract][Full Text] [Related]
38. Hypercalcemia with elevated dihydroxycholecalciferol levels and hypercalciuria. A parathyroid concentration-independent mechanism.
Silver J; Popovtzer MM
Arch Intern Med; 1984 Jan; 144(1):162-3. PubMed ID: 6691752
[TBL] [Abstract][Full Text] [Related]
39. [Usefulness of jugular vein catheterization and parathyroid hormone radioimmunoassay in recurring renal calcium lithiasis].
Bernheim J; David L; Pinet A; Labeeuw M; Zech P; Traeger J
J Urol Nephrol (Paris); 1975; 81(4-5):299-311. PubMed ID: 1159889
[No Abstract] [Full Text] [Related]
40. [Studies of calcium metabolism in patients with hypercalciuria].
Bichler KH; Strohmaier WL; Mittermüller B
Urologe A; 1996 Sep; 35(5):408-12. PubMed ID: 8999631
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
